Search research articles
Contact Us
Filters
Showing results (341-350 of 395) with videos related to
Page
of 40
Sort By:
Gene Therapy
|
April 16, 1998
Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles
S S Floyd, P R Clemens, M R Ontell, et al.
AIDS (London, England)
|
January 6, 1999
Increased protected sex and abstinence among Namibian youth following a HIV risk-reduction intervention: a randomized, longitudinal study
B F Stanton, X Li, J Kahihuata, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 2, 2008
Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie
S-E Al-Batran, J T Hartmann, R Hofheinz, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
April 25, 2015
Feasibility and Reproducibility of Echocardiographic Measures in Children with Muscular Dystrophies
Christopher F Spurney, Francis M McCaffrey, Avital Cnaan, et al.
Steroids
|
September 16, 2025
Mineralocorticoid receptor antagonism of vamorolone: Evidence from LIONHEART and VISION-DMD clinical trials
Ana de Vera, Paula R Clemens, Utkarsh J Dang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 16, 1999
Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy
R Rizzoli, D Thiébaud, N Bundred, et al.
Plos One
|
April 16, 2016
Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study
Simina M Boca, Maki Nishida, Michael Harris, et al.
JAMA Neurology
|
May 27, 2020
Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial
Paula R Clemens, Vamshi K Rao, Anne M Connolly, et al.
Anti-Cancer Drugs
|
September 23, 2009
Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer: an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the 'Arbeitsgemeinschaft Internistische Onkologie'
Stefan Boeck, Ursula Vehling-Kaiser, Dirk Waldschmidt, et al.
Scientific Reports
|
August 23, 2019
Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne Muscular Dystrophy
Yetrib Hathout, Chen Liang, Michael Ogundele, et al.
Page
of 40
Search research articles
Search
Showing results (341-350 of 395) with videos related to
Sort By:
Page
of 40
Gene Therapy
|
April 16, 1998
Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles
S S Floyd, P R Clemens, M R Ontell, et al.
AIDS (London, England)
|
January 6, 1999
Increased protected sex and abstinence among Namibian youth following a HIV risk-reduction intervention: a randomized, longitudinal study
B F Stanton, X Li, J Kahihuata, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 2, 2008
Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie
S-E Al-Batran, J T Hartmann, R Hofheinz, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
April 25, 2015
Feasibility and Reproducibility of Echocardiographic Measures in Children with Muscular Dystrophies
Christopher F Spurney, Francis M McCaffrey, Avital Cnaan, et al.
Steroids
|
September 16, 2025
Mineralocorticoid receptor antagonism of vamorolone: Evidence from LIONHEART and VISION-DMD clinical trials
Ana de Vera, Paula R Clemens, Utkarsh J Dang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 16, 1999
Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy
R Rizzoli, D Thiébaud, N Bundred, et al.
Plos One
|
April 16, 2016
Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study
Simina M Boca, Maki Nishida, Michael Harris, et al.
JAMA Neurology
|
May 27, 2020
Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial
Paula R Clemens, Vamshi K Rao, Anne M Connolly, et al.
Anti-Cancer Drugs
|
September 23, 2009
Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer: an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the 'Arbeitsgemeinschaft Internistische Onkologie'
Stefan Boeck, Ursula Vehling-Kaiser, Dirk Waldschmidt, et al.
Scientific Reports
|
August 23, 2019
Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne Muscular Dystrophy
Yetrib Hathout, Chen Liang, Michael Ogundele, et al.
Page
of 40